The agreement expands on an existing partnership and grants Psyence the right to commercialize Filament’s natural psilocybin drug candidate PEX010 …
SEATTLE, Sept. 15, 2022 /PRNewswire/ — LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular …
DRI Healthcare Trust today announced that a wholly-owned subsidiary of DRI has acquired a royalty interest in Zejula from AnaptysBio, …
Phanes Therapeutics, Inc., an emerging leader in innovative discovery research and clinical development in oncology, announced today that the U.S. …
Crown Therapeutics, a division of Crown Laboratories, is pleased to announce a partnership with Actress, Bailee Madison, who is joining …
Ionis Pharmaceuticals, Inc., today announced that its long-standing partner, Roche, will license and advance IONIS-FB-LRx, an investigational antisense medicine, into …
Theralink Technologies, a precision medicine company with a novel phosphoprotein-based assay for breast cancer, today announced that it will host …
Development program for VLX-1005, a novel small molecule 12-LOX inhibitor, awarded Fast Track designation by US Food and Drug Administration …
Study leverages deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to …
The non-medical home care company hosts networking event and an awards ceremony for franchisees in the Dominican Republic SAN ANTONIO, …
